Hypomelanotic Disorder Clinical Trials

Find Hypomelanotic Disorder Clinical Trials Near You

An Observational Study of Patients With Dermatologic Disease

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.

• Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.

Locations
United States
North Carolina
Wake Forest University Health Science
RECRUITING
Winston-salem
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Contact Information
Primary
Lynda Lee Burch
lburch@pedestalhealth.com
9842340268
Backup
Danisha Devane
ddevane@pedestalhealth.com
9842340268
Time Frame
Start Date: 2026-08-01
Estimated Completion Date: 2041-08-03
Participants
Target number of participants: 2000000
Treatments
Disease Cohort
Adult patients and patients under the age of majority with a diagnosis of DD by ICD or other relevant healthcare code in the EHR interface.
Engaged Cohort
Adult patients and patients under the age of majority diagnosed and managed for DD invited to participate OR HCPs who treat patients with these conditions.~* Informed consent is required for all participants in an Engaged Cohort.~* Willing to complete required Engaged Cohort activities.
Sponsors
Leads: Target PharmaSolutions, Inc.

This content was sourced from clinicaltrials.gov